SCOUT INVESTMENTS, INC. - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 9 filers reported holding Astellas Pharma Inc in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SCOUT INVESTMENTS, INC. ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q4 2021$3,665,000
-1.7%
225,247
-0.2%
0.05%
-5.4%
Q3 2021$3,728,000
+27.7%
225,689
+19.4%
0.06%
+27.3%
Q1 2021$2,919,000
+2.3%
189,081
+2.3%
0.04%
-15.4%
Q4 2020$2,854,000
-15.1%
184,816
-18.1%
0.05%
-30.7%
Q3 2020$3,363,000
+19.1%
225,581
+33.1%
0.08%
+10.3%
Q2 2020$2,823,000
-16.6%
169,423
-23.7%
0.07%
-32.7%
Q1 2020$3,386,000
-23.6%
222,187
-14.6%
0.10%
+17.4%
Q4 2019$4,431,000
+19.6%
260,1990.0%0.09%
+16.2%
Q3 2019$3,704,000
-15.5%
260,199
-15.5%
0.07%
-12.9%
Q2 2019$4,385,000
+38.9%
307,783
+46.1%
0.08%
+30.8%
Q1 2019$3,156,000
+45.7%
210,640
+24.2%
0.06%
+20.4%
Q4 2018$2,166,000
-33.4%
169,589
-9.0%
0.05%
-19.4%
Q3 2018$3,252,000
-11.5%
186,380
-22.6%
0.07%
-20.2%
Q2 2018$3,674,000
+4.5%
240,903
+4.1%
0.08%0.0%
Q1 2018$3,516,000
-2.5%
231,381
-18.2%
0.08%
-5.6%
Q4 2017$3,607,000
+1.3%
282,734
+1.0%
0.09%
-9.2%
Q3 2017$3,559,000
+6.9%
279,876
+2.8%
0.10%
+2.1%
Q2 2017$3,330,000
+11.5%
272,200
+19.9%
0.10%
+17.1%
Q1 2017$2,987,000
+6.5%
227,032
+12.7%
0.08%
+5.1%
Q4 2016$2,804,000
+0.4%
201,453
+12.1%
0.08%0.0%
Q3 2016$2,792,000
+49.1%
179,686
+49.7%
0.08%
+50.0%
Q2 2016$1,872,000
+75.8%
120,046
+50.1%
0.05%
+79.3%
Q1 2016$1,065,000
-6.5%
79,995
+1.1%
0.03%0.0%
Q4 2015$1,139,000
+659.3%
79,122
+578.3%
0.03%
+866.7%
Q3 2015$150,000
-9.6%
11,6640.0%0.00%0.0%
Q2 2015$166,000
-16.2%
11,664
-3.5%
0.00%0.0%
Q1 2015$198,00012,0890.00%
Other shareholders
Astellas Pharma Inc shareholders Q3 2023
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 391,745$5,438,8800.25%
Cassady Schiller Wealth Management, LLC 698$9,6670.01%
MAI Capital Management 19,087$264,3620.00%
SVB WEALTH LLC 10,472$145,0370.00%
RHUMBLINE ADVISERS 34,759$481,4080.00%
First Horizon Advisors, Inc. 114$1,5780.00%
Operose Advisors LLC 90$1,2470.00%
Russell Investments Group, Ltd. 783$10,8450.00%
PNC FINANCIAL SERVICES GROUP, INC. 166$2,2990.00%
View complete list of Astellas Pharma Inc shareholders